Safety of adjunctive treatment with cenobamate in patients with uncontrolled focal seizures

Affiliations

¹ Le Bonheur Comprehensive Epilepsy Program & Neuroscience Institute, Le Bonheur Children's Hospital, Memphis, TN 38103, USA; Division of Pediatric Neurology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address: bmudigou@uthsc.edu.
² Le Bonheur Comprehensive Epilepsy Program & Neuroscience Institute, Le Bonheur Children's Hospital, Memphis, TN 38103, USA; Division of Pediatric Neurology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.

Comment

Basanagoud Mudigoudar et al. Lancet Neurol. 2020 Apr.

. 2020 Apr;19(4):288.

doi: 10.1016/S1474-4422(20)30069-7. Epub 2020 Mar 18.

¹ Le Bonheur Comprehensive Epilepsy Program & Neuroscience Institute, Le Bonheur Children's Hospital, Memphis, TN 38103, USA; Division of Pediatric Neurology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address: bmudigou@uthsc.edu.
² Le Bonheur Comprehensive Epilepsy Program & Neuroscience Institute, Le Bonheur Children's Hospital, Memphis, TN 38103, USA; Division of Pediatric Neurology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.

No abstract available

Comment in

Safety of adjunctive treatment with cenobamate in patients with uncontrolled focal seizures - Authors' reply.
Krauss GL, Klein P, Brandt C, Lee SK, Milanov I, Milovanovic M, Steinhoff BJ, Kamin M. Krauss GL, et al. Lancet Neurol. 2020 Apr;19(4):288-289. doi: 10.1016/S1474-4422(20)30077-6. Epub 2020 Mar 18. Lancet Neurol. 2020. PMID: 32199090 No abstract available.

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
Krauss GL, Klein P, Brandt C, Lee SK, Milanov I, Milovanovic M, Steinhoff BJ, Kamin M. Krauss GL, et al. Lancet Neurol. 2020 Jan;19(1):38-48. doi: 10.1016/S1474-4422(19)30399-0. Epub 2019 Nov 14. Lancet Neurol. 2020. PMID: 31734103 Clinical Trial.